Northwestern Mutual Wealth Management
BBIO icon

Northwestern Mutual Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
174
+82
+89% +$5.74K ﹤0.01% 3027
2026
Q1 		$6.83K Hold
92
– – ﹤0.01% 3199
2025
Q4 		$7.04K Sell
92
-139
-60% -$9.12K ﹤0.01% 3110
2025
Q3 		$12K Buy
231
+23
+11% +$1.12K ﹤0.01% 2846
2025
Q2 		$8.98K Buy
+208
New +$7.57K ﹤0.01% 2832

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Northwestern Mutual Wealth Management's BBIO Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its BridgeBio Pharma (BBIO) stake by 89% in Q2 2026, buying an estimated $5.74K and bringing the position to 174 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

Northwestern Mutual Wealth Management first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Northwestern Mutual Wealth Management held 174 shares of BridgeBio Pharma worth $13K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 82 BridgeBio Pharma shares in Q2 2026, an estimated $5.74K.
  • BridgeBio Pharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3027 holding.
  • Northwestern Mutual Wealth Management first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.